Literature DB >> 29200425

Correction: A systematic review and meta-analysis of preclinical trials testing anti-toxin therapies for B. anthracis infection: A need for more robust study designs and results.

Wanying Xu, Lernik Ohanjanian, Junfeng Sun, Xizhong Cui, Dante Suffredini, Yan Li, Judith Welsh, Peter Q Eichacker.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0182879.].

Entities:  

Year:  2017        PMID： 29200425      PMCID： PMC5714336          DOI： 10.1371/journal.pone.0189239

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


The second author's name is spelled incorrectly. The correct name is: Lernik Ohanjanian. The correct citation is: Xu W, Ohanjanian L, Sun J, Cui X, Suffredini D, Li Y, et al. (2017) A systematic review and meta-analysis of preclinical trials testing anti-toxin therapies for B. anthracis infection: A need for more robust study designs and results. PLoS ONE12(8): e0182879. https://doi.org/10.1371/journal.pone.0182879
  1 in total

Review 1.  A systematic review and meta-analysis of preclinical trials testing anti-toxin therapies for B. anthracis infection: A need for more robust study designs and results.

Authors:  Wanying Xu; Lernik Ohanjanian; Junfeng Sun; Xizhong Cui; Dante Suffredini; Yan Li; Judith Welsh; Peter Q Eichacker
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240
  1 in total
  2 in total

Review 1.  Current Status and Trends in Prophylaxis and Management of Anthrax Disease.

Authors:  Vladimir Savransky; Boris Ionin; Joshua Reece
Journal:  Pathogens       Date:  2020-05-12

2.  Very Early Blood Diffusion of the Active Lethal and Edema Factors of Bacillus anthracis After Intranasal Infection.

Authors:  Clémence Rougeaux; François Becher; Pierre L Goossens; Jean-Nicolas Tournier
Journal:  J Infect Dis       Date:  2020-02-03       Impact factor: 5.226
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.